Reaction
Pseudoporphyria reporting signals
As of the last recalculation, Pseudoporphyria appears in 336 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is IMATINIB (PRR 141.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Imatinib | 36 | 141.5 | 141.8 |
| Voriconazole | 23 | 50.3 | 50.3 |
| Febuxostat Tablets 40 Mg | 8 | 49.9 | 49.9 |
| Febuxostat Tablets 80 Mg | 8 | 49.9 | 49.9 |
| Naproxen Sodium Tablet, Coated | 9 | 42.3 | 42.3 |
| Naproxen Sodium, Coated Tablets | 9 | 42.3 | 42.3 |
| Naproxen Sodium 220Mg | 9 | 42.2 | 42.2 |
| Voriconazole Injection | 13 | 38.5 | 38.6 |
| Paricalcitol | 5 | 22.2 | 22.3 |